Sang Won Eom
Sungkyunkwan University · 医学
研究室紹介
Professor Sang Won Eom's research lab specializes in translational pulmonary and oncology research, focusing on improving diagnostic accuracy and treatment strategies for lung cancer and respiratory diseases. Key research directions include the application of molecular imaging techniques such as ¹⁸F-FDG PET/CT and liquid biopsy using cell-free DNA methylation patterns for early cancer detection and nodal staging. The lab also investigates innovative endoscopic techniques like EBUS-TBNA and EUS-FNA-B/E for mediastinal lymph node evaluation, and explores epigenetic biomarkers in bronchial washings for early lung cancer detection. Additionally, the lab examines therapeutic interventions in chronic respiratory diseases, such as COPD, with a focus on optimizing inhaled therapies.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15BACKGROUND AND OBJECTIVE: The introduction of ¹⁸F-FDG PET/CT has enhanced the diagnostic accuracy of nodal staging for non-small cell lung cancer (NSCLC). We analysed risk factors for occult nodal metastasis in patients with clinical stage IA NSCLC as determined by ¹⁸F-FDG PET/CT. METHODS: Data for 147 patients diagnosed as clinical stage IA NSCLC by PET/CT from 2005 to 2007 were retrospectively reviewed. All study patients underwent ¹⁸F-FDG PET/CT for lung cancer staging. They also underwent ce
Use of a combination of EBUS-TBNA and EUS-FNA-B/E can afford better sensitivity and accuracy of mediastinal N-staging compared with use of EBUS-TBNA alone. Such combined procedures should be considered for examination of lesions that are inaccessible or difficult to access by EBUS-TBNA.
Methylation patterns in cell-free DNA (cfDNA) have emerged as a promising genomic feature for detecting the presence of cancer and determining its origin. The purpose of this study was to evaluate the diagnostic performance of methylation-sensitive restriction enzyme digestion followed by sequencing (MRE-Seq) using cfDNA, and to investigate the cancer signal origin (CSO) of the cancer using a deep neural network (DNN) analyses for liquid biopsy of colorectal and lung cancer. We developed a selec
The present study suggests that NSCLC may be detected by analyzing methylation changes of seven CpGs in bronchial washings. Furthermore, smoking cessation may lead to decreased DNA methylation in nonmalignant bronchial epithelial cells in a gene-specific manner.
BACKGROUND AND OBJECTIVE: We evaluated effective treatments of broncholithiasis based on its radiographical and bronchoscopic features. METHODS: This retrospective study conducted at Samsung Medical Center, Korea enrolled patients who were suspected of having broncholithiasis based on chest computed tomography (CT). The broncholiths were classified as intraluminal, mixed (both intraluminal and extraluminal) and extraluminal based on chest CT and bronchoscopic findings. RESULTS: The study enrolle
Endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA) offers a minimally invasive option for staging the mediastinum in suspected lung cancer but also in the diagnosis of mediastinal lesions accessible from the airways. EBUS-TBNA has been widely used for the evaluation of mediastinal and hilar lesions for several reasons, such as its minimally invasive nature, high diagnostic accuracy, needle aspiration under real-time visualization and excellent safety profile. Several recent st
Because additive effects of inhaled corticosteroids and long-acting anticholinergics are unclear, we undertook this study to compare the efficacy of tiotropium alone and tiotropium plus budesonide in patients with chronic obstructive pulmonary disease. The study subjects were randomized to receive either tiotropium 18 microg once daily with or without budesonide 200 microg twice daily for 6 weeks. The efficacy variables were changes in trough forced expiratory volume in one second (FEV1), St. Ge
Non-small cell lung cancer (NSCLC) with brain metastasis is the most common central nervous system malignancy, accounting for as much as 20% of every brain metastasis case (1). The incidence of brain metastasis has been increasing due to improvements in the control of systemic extra-cranial disease and the widespread availability of imaging modalities such as magnetic resonance imaging (MRI), which has increased the detection of subclinical disease (2-4).